BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Sunday, February 15, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
April 16, 2020
View Archived Issues
The next pandemic: speeding development and stretching supplies
Read More
Gut repair with an iron will
Read More
Eight newly identified loci are involved in the susceptibility to cutaneous SCC, large GWAS shows
Read More
Rac1 overexpression is involved in breast cancer chemoresistance by influencing DNA damage repair
Read More
FDA authorizes phase II study of MultiStem cell therapy in trauma patients
Read More
Chinese regulatory approval granted to initiate phase II/III study of HBM-9161 in ITP
Read More
TScan and Novartis collaborate to develop novel TCR-engineered T-cell therapies
Read More
Novel hBCR/ABL1-induced zebrafish model of CML
Read More
EM2D9 antibody shows potent antitumor activity in preclinical models of endometrial cancer
Read More
New Toll-like receptor 7 agonists discovered at Bristol-Myers Squibb
Read More
Shenzhen Edk Pharmaceutical Technology patents androgen receptor antagonists
Read More
Betta Pharmaceuticals discloses new FGFR-4 inhibitors
Read More
Shanghai Ennova Biopharmaceutical describes new SSAO inhibitors
Read More
OncoImmune initiates phase III study with CD24Fc for COVID-19
Read More
New MAP3K5 inhibitors identified at XuanZhu Pharma
Read More
New ANKRD26-RET fusion gene found in papillary thyroid carcinoma
Read More
Galapagos and Ryvu establish research collaboration in inflammation
Read More
Roivant initiates pivotal trial of gimsilumab for prevention and treatment of COVID-19-related ARDS
Read More
FDA approves Jelmyto for low-grade upper tract urothelial cancer
Read More
Vir reports interim data from ongoing phase II study of VIR-2218 for chronic HBV infection
Read More
SPL-7013 demonstrates significant activity against SARS-CoV-2 in lab studies
Read More
Gilead Sciences begins phase III trial of remdesivir for the treatment of COVID-19 in Japan
Read More
